Abstract
In the acute promyelocytic leukemia (APL) bearing the t(15;17), all-trans-retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. We identified miR-342 as one of the microRNAs (miRNAs) upregulated by ATRA during APL differentiation. This miRNA emerged as a direct transcriptional target of the critical hematopoietic transcription factors PU.1 and interferon regulatory factor (IRF)-1 and IRF-9. IRF-1 maintains miR-342 at low levels, whereas the binding of PU.1 and IRF-9 in the promoter region following retinoic ATRA-mediated differentiation, upregulates miR-342 expression. Moreover, we showed that enforced expression of miR-342 in APL cells stimulated ATRA-induced differentiation. These data identified miR-342 as a new player in the granulocytic differentiation program activated by ATRA in APL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Melnick A, Licht JD . Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167–3215.
Lo Coco F, Zelent A, Kimchi A, Carducci M, Gore SD, Waxman S . Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. Cancer Res 2002; 62: 5618–5621.
Tenen DG . Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003; 3: 89–101.
Shivdasani RA . MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006; 108: 3646–3653.
Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA . MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 2008; 22: 1095–2105.
Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007; 26: 4148–4157.
Fatica A, Rosa A, Ballarino M, De Marchis ML, Rasmussen KD, Bozzoni I . Role of microRNAs in myeloid differentiation. Biochem Soc Trans 2008; 36: 1201–1205.
Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008; 27: 3880–3888.
Taniguchi T, Ogasawara K, Takaoka A, Tanaka N . IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623–655.
Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C et al. A mini-circuitry comprising microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 2005; 123: 819–831.
Denti MA, Rosa A, Sthandier O, De Angelis FG, Bozzoni I . A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 2004; 10: 191–199.
Chakrabarti SK, James JC, Mirmira RG . Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem 2002; 277: 13286–13293.
Roussel MJ, Lanotte M . Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes. Oncogene 2001; 20: 7287–7291.
Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451: 1125–1129.
Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, Fabris S et al. An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics 2008; 1: 37.
Marinescu VD, Kohane IS, Riva A . MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005; 6: 79.
Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I . Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 1996; 88: 114–123.
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 2006; 107: 3330–3338.
Everett LM, Crabb DW . Sensitivity of virally-driven luciferase reporter plasmids to members of the steroid/thyroid/retinoid family of nuclear receptors. J Steroid Biochem Mol Biol 1999; 70: 197–201.
Nerlov C, Graf T . PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev 1998; 12: 2403–2412.
Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968–971.
Testa U, Stellacci E, Pelosi E, Sestili P, Venditti M, Orsatti R et al. Impaired myelopoiesis in mice devoid of interferon regulatory factor 1. Leukemia 2004; 18: 1864–1871.
Acknowledgements
We thank O Sthandier and M Marchioni for cell cultures and M Arceci for technical assistance. This work was partially supported by grants from: AIRC and AIRC-ROC, Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004 005276) and SIROCCO (Grant LSHG-CT-2006–037900), PRIN and ‘Centro di eccellenza BEMM’.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
De Marchis, M., Ballarino, M., Salvatori, B. et al. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 23, 856–862 (2009). https://doi.org/10.1038/leu.2008.372
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/leu.2008.372
Keywords
This article is cited by
-
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision
Leukemia (2021)
-
Modulation of all-trans retinoic acid-induced MiRNA expression in neoplastic cell lines: a systematic review
BMC Cancer (2019)
-
UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313
Cell Death & Disease (2019)
-
ATRA induces the differentiation of hepatic progenitor cells by upregulating microRNA-200a
In Vitro Cellular & Developmental Biology - Animal (2019)
-
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report
Cellular Oncology (2016)


